AU2010295512B2 - Methods and composition for diagnosis and prognosis of renal injury and renal failure - Google Patents

Methods and composition for diagnosis and prognosis of renal injury and renal failure Download PDF

Info

Publication number
AU2010295512B2
AU2010295512B2 AU2010295512A AU2010295512A AU2010295512B2 AU 2010295512 B2 AU2010295512 B2 AU 2010295512B2 AU 2010295512 A AU2010295512 A AU 2010295512A AU 2010295512 A AU2010295512 A AU 2010295512A AU 2010295512 B2 AU2010295512 B2 AU 2010295512B2
Authority
AU
Australia
Prior art keywords
cohort
subject
scr
threshold
prior
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU2010295512A
Other languages
English (en)
Other versions
AU2010295512A1 (en
Inventor
Joseph Anderberg
Jeff Gray
James Patrick Kampf
Paul Mcpherson
Kevin Nakamura
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Astute Medical Inc
Original Assignee
Astute Medical Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astute Medical Inc filed Critical Astute Medical Inc
Publication of AU2010295512A1 publication Critical patent/AU2010295512A1/en
Application granted granted Critical
Publication of AU2010295512B2 publication Critical patent/AU2010295512B2/en
Priority to AU2015200953A priority Critical patent/AU2015200953A1/en
Ceased legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6854—Immunoglobulins
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/745—Assays involving non-enzymic blood coagulation factors
    • G01N2333/7452—Thrombomodulin
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/81—Protease inhibitors
    • G01N2333/8107—Endopeptidase (E.C. 3.4.21-99) inhibitors
    • G01N2333/8146—Metalloprotease (E.C. 3.4.24) inhibitors, e.g. tissue inhibitor of metallo proteinase, TIMP
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/34—Genitourinary disorders
    • G01N2800/347—Renal failures; Glomerular diseases; Tubulointerstitial diseases, e.g. nephritic syndrome, glomerulonephritis; Renovascular diseases, e.g. renal artery occlusion, nephropathy
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/56—Staging of a disease; Further complications associated with the disease

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Biotechnology (AREA)
  • Analytical Chemistry (AREA)
  • Cell Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
AU2010295512A 2009-09-18 2010-09-17 Methods and composition for diagnosis and prognosis of renal injury and renal failure Ceased AU2010295512B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU2015200953A AU2015200953A1 (en) 2009-09-18 2015-02-25 Methods and composition for diagnosis and prognosis of renal injury and renal failure

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US24399509P 2009-09-18 2009-09-18
US24400009P 2009-09-18 2009-09-18
US61/243,995 2009-09-18
US61/244,000 2009-09-18
US25463609P 2009-10-23 2009-10-23
US61/254,636 2009-10-23
PCT/US2010/049234 WO2011035097A1 (en) 2009-09-18 2010-09-17 Methods and composition for diagnosis and prognosis of renal injury and renal failure

Related Child Applications (1)

Application Number Title Priority Date Filing Date
AU2015200953A Division AU2015200953A1 (en) 2009-09-18 2015-02-25 Methods and composition for diagnosis and prognosis of renal injury and renal failure

Publications (2)

Publication Number Publication Date
AU2010295512A1 AU2010295512A1 (en) 2012-04-05
AU2010295512B2 true AU2010295512B2 (en) 2014-12-18

Family

ID=43759017

Family Applications (2)

Application Number Title Priority Date Filing Date
AU2010295512A Ceased AU2010295512B2 (en) 2009-09-18 2010-09-17 Methods and composition for diagnosis and prognosis of renal injury and renal failure
AU2015200953A Abandoned AU2015200953A1 (en) 2009-09-18 2015-02-25 Methods and composition for diagnosis and prognosis of renal injury and renal failure

Family Applications After (1)

Application Number Title Priority Date Filing Date
AU2015200953A Abandoned AU2015200953A1 (en) 2009-09-18 2015-02-25 Methods and composition for diagnosis and prognosis of renal injury and renal failure

Country Status (10)

Country Link
US (2) US20130045494A1 (enExample)
EP (2) EP2470904A4 (enExample)
JP (3) JP2013513086A (enExample)
CN (2) CN105004864B (enExample)
AU (2) AU2010295512B2 (enExample)
CA (1) CA2773905A1 (enExample)
EA (1) EA201290106A1 (enExample)
MX (1) MX2012003168A (enExample)
NZ (2) NZ598741A (enExample)
WO (1) WO2011035097A1 (enExample)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2721907T3 (es) * 2011-08-26 2019-08-06 Astute Medical Inc Métodos y composiciones para el diagnóstico y pronóstico de lesión renal e insuficiencia renal
JP6532460B2 (ja) * 2013-07-26 2019-06-19 コーニンクレッカ フィリップス エヌ ヴェＫｏｎｉｎｋｌｉｊｋｅ Ｐｈｉｌｉｐｓ Ｎ．Ｖ． 患者モニタリングシステムに関する臨床規則及び規定のコンピュータ化及び視覚化
GB201501597D0 (en) * 2015-01-30 2015-03-18 Randox Lab Ltd Thrombomodulin
CN108271422A (zh) 2015-06-25 2018-07-10 株式会社国际电气通信基础技术研究所 基于器官间串扰系统的预测装置及预测程序
WO2017130985A1 (ja) * 2016-01-29 2017-08-03 株式会社国際電気通信基礎技術研究所 腎機能の評価装置、腎疾患の合併症の発症の予測装置、およびリン摂取量推定装置
JP6432962B2 (ja) 2016-03-29 2018-12-05 株式会社国際電気通信基礎技術研究所 腎機能低下、慢性腎疾患及び腎不全からなる群から選択される少なくとも一種の疾患を予防、又は治療するための有効成分の候補物質のスクリーニング方法
JP6332780B2 (ja) 2016-03-29 2018-05-30 株式会社国際電気通信基礎技術研究所 医薬組成物又は食品組成物、及び有効成分の体内での効果の評価方法

Family Cites Families (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5223409A (en) 1988-09-02 1993-06-29 Protein Engineering Corp. Directed evolution of novel binding proteins
US5939272A (en) 1989-01-10 1999-08-17 Biosite Diagnostics Incorporated Non-competitive threshold ligand-receptor assays
US5028535A (en) 1989-01-10 1991-07-02 Biosite Diagnostics, Inc. Threshold ligand-receptor assay
JPH0736019B2 (ja) * 1989-12-27 1995-04-19 富士薬品工業株式会社 新規な抗ヒトトロンボモジュリンモノクローナル抗体によるヒトトロンボモジュリンおよびその分解産物の定量方法
US5922615A (en) 1990-03-12 1999-07-13 Biosite Diagnostics Incorporated Assay devices comprising a porous capture membrane in fluid-withdrawing contact with a nonabsorbent capillary network
WO1992005282A1 (en) 1990-09-14 1992-04-02 Biosite Diagnostics, Inc. Antibodies to complexes of ligand receptors and ligands and their utility in ligand-receptor assays
US5955377A (en) 1991-02-11 1999-09-21 Biostar, Inc. Methods and kits for the amplification of thin film based assays
ATE177841T1 (de) 1991-04-10 1999-04-15 Biosite Diagnostics Inc ''crosstalk''- oder übersprech-inhibitoren und ihre verwendung
EP0579767B1 (en) 1991-04-11 2000-08-23 Biosite Diagnostics Inc. Novel conjugates and assays for simultaneous detection of multiple ligands
US6143576A (en) 1992-05-21 2000-11-07 Biosite Diagnostics, Inc. Non-porous diagnostic devices for the controlled movement of reagents
US5885527A (en) 1992-05-21 1999-03-23 Biosite Diagnostics, Inc. Diagnostic devices and apparatus for the controlled movement of reagents without membrances
US5494829A (en) 1992-07-31 1996-02-27 Biostar, Inc. Devices and methods for detection of an analyte based upon light interference
US5824799A (en) 1993-09-24 1998-10-20 Biosite Diagnostics Incorporated Hybrid phthalocyanine derivatives and their uses
CN1129666C (zh) * 1994-12-13 2003-12-03 人体基因组科学有限公司 金属蛋白酶－4的人组织抑制剂
CN1495258A (zh) * 1994-12-13 2004-05-12 人体基因组科学有限公司 金属蛋白酶-4的人组织抑制剂
US6544761B2 (en) * 1994-12-13 2003-04-08 Human Genome Sciences, Inc. Human tissue inhibitor of metalloproteinase-4
US6113855A (en) 1996-11-15 2000-09-05 Biosite Diagnostics, Inc. Devices comprising multiple capillarity inducing surfaces
US5947124A (en) 1997-03-11 1999-09-07 Biosite Diagnostics Incorporated Diagnostic for determining the time of a heart attack
US6057098A (en) 1997-04-04 2000-05-02 Biosite Diagnostics, Inc. Polyvalent display libraries
WO2001042438A2 (en) * 1999-12-13 2001-06-14 Regents Of The University Of Minnesota Leukolysin/mmp25/mt6-mmp
JP2004535765A (ja) * 2000-12-07 2004-12-02 カイロン コーポレイション 前立腺癌においてアップレギュレートされた内因性レトロウイルス
CA2453538A1 (en) * 2001-07-12 2003-01-23 Kyowa Medex Co., Ltd. Method for determination of denatured lipoprotein, reagent for determination of denatured lipoprotein, method for detection of cardiovascular disease, and reagent for detection ofcardiovascular disease
EP1742650A1 (en) * 2004-03-30 2007-01-17 Den Kgl.Veterin R-Og Landboh Jskole Improvements in cancer treatment and cancer treatment efficacy prediction by blocking and detecting protease inhibitors
US7713693B1 (en) * 2004-09-01 2010-05-11 University Of Louisiana At Monroe Human cancer cell specific gene transcript
US20060160112A1 (en) * 2004-12-02 2006-07-20 Erdal Cavusoglu Tissue inhibitor of metalloproteinase (TIMP) as a marker and predictor of cardiovascular disease and both cardiac and non-cardiac mortality
US20090178145A1 (en) * 2005-05-11 2009-07-09 The Procter & Gamble Company Methods and targets for identifying compounds for regulating angiogenesis
WO2007053610A2 (en) * 2005-11-01 2007-05-10 The Regents Of The University Of California Methods of treating atrial fibrillation wtih pirfenidone
JP2007163151A (ja) * 2005-12-09 2007-06-28 Kitasato Gakuen 対象生物の生理状態を判定する方法
AU2007249620A1 (en) * 2006-05-09 2007-11-22 Musc Foundation For Research Development Detecting diastolic heart failure by protease and protease inhibitor plasma profiling
CN101490273A (zh) * 2006-05-09 2009-07-22 南卡罗来纳州医科大学研究发展基金会 利用蛋白酶和蛋白酶抑制剂血浆分析检测舒张期心力衰竭
WO2008084331A2 (en) * 2006-06-21 2008-07-17 Hopitaux Universitaires De Geneve Biomarkers for renal disorders
RU2009104460A (ru) * 2006-07-11 2010-08-20 Маск Фаундейшн Фор Рисерч Дивелопмент (Us) Прогнозирование сердечной недостаточности после инфаркта миокарда по профилю протеаз и ингибиторов протеаз
GB0617429D0 (en) * 2006-09-05 2006-10-18 Electrophoretics Ltd Markers of renal transplant rejection and renal damage
EP2095107B1 (en) * 2006-11-14 2014-07-02 Alere San Diego, Inc. Methods for risk assignment
FR2909180B1 (fr) * 2006-11-29 2009-02-20 Diagnostica Stago Soc Par Acti Methode de mesure fonctionnelle de l'activite de la thrombomoduline plasmatique.

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
Coca, S.G. et al., Kidney International. 2008 vol. 73 pages 1008-1016 *

Also Published As

Publication number Publication date
CN105004864A (zh) 2015-10-28
EP2470904A1 (en) 2012-07-04
CN105004864B (zh) 2017-11-03
US20190250170A1 (en) 2019-08-15
JP2013513086A (ja) 2013-04-18
CN102576012B (zh) 2015-07-15
CN102576012A (zh) 2012-07-11
JP6403712B2 (ja) 2018-10-10
EA201290106A1 (ru) 2012-12-28
JP2015129764A (ja) 2015-07-16
EP2470904A4 (en) 2013-05-01
AU2015200953A1 (en) 2015-03-12
HK1212774A1 (zh) 2016-06-17
NZ612673A (en) 2014-10-31
HK1167889A1 (zh) 2012-12-14
US20130045494A1 (en) 2013-02-21
JP2016176953A (ja) 2016-10-06
MX2012003168A (es) 2012-05-08
CA2773905A1 (en) 2011-03-24
AU2010295512A1 (en) 2012-04-05
WO2011035097A1 (en) 2011-03-24
EP3299821A1 (en) 2018-03-28
NZ598741A (en) 2013-07-26

Similar Documents

Publication Publication Date Title
US9417250B2 (en) Methods and compositions for diagnosis and prognosis of renal injury and renal failure
AU2009316387B2 (en) Methods and compositions for diagnosis and prognosis of renal injury and renal failure
AU2010210540B2 (en) Methods and compositions for diagnosis and prognosis of renal injury and failure
AU2020201732A1 (en) Methods and compositions for diagnosis and prognosis of renal injury and renal failure
US9366683B2 (en) Methods for diagnosis and prognosis of renal injury and renal failure
AU2010295287A1 (en) Methods and compositions for diagnosis and prognosis of renal injury and renal failure
AU2012312907A1 (en) Methods and compositions for diagnosis and prognosis of renal injury and renal failure
AU2015336069B2 (en) Methods and compositions for diagnosis and prognosis of renal injury and renal failure
US20130157881A1 (en) Methods and compositions for diagnosis and prognosis of renal injury and renal failure
AU2010286559A1 (en) Methods and compositions for diagnosis and prognosis of renal injury and renal failure
US20120231476A1 (en) Methods and compositions for diagnosis and prognosis of renal injury and renal failure
US20190250170A1 (en) Methods and compositions for diagnosis and prognosis of renal injury and renal failure
AU2012282918A1 (en) Methods and compositions for diagnosis and prognosis of renal injury and renal failure
AU2011213685B2 (en) Methods and compositions for diagnosis and prognosis of renal injury and renal failure
US20160313350A1 (en) Methods for diagnosis and prognosis of renal injury and renal failure using trefoil factor 3 failure
US20170315134A1 (en) Methods and compositions for diagnosis and prognosis of renal injury and renal failure
US20190120858A1 (en) Methods for evaluating renal injury and renal failure using urine levels of chitinase-3-like protein 1
AU2013226181A1 (en) Methods and compositions for diagnosis and prognosis of renal injury and renal failure
AU2013296231A1 (en) Methods and compositions for diagnosis and prognosis of renal injury and renal failure
US20180164328A1 (en) Methods and compositions for diagnosis and prognosis of renal injury and renal failure
AU2015202151A1 (en) Methods and compositions for diagnosis and prognosis of renal injury and renal failure
AU2014277715A1 (en) Methods and compositions for diagnosis and prognosis of renal injury and renal failure
AU2014212609A1 (en) Methods and compositions for diagnosis and prognosis of renal injury and renal failure

Legal Events

Date Code Title Description
FGA Letters patent sealed or granted (standard patent)
MK14 Patent ceased section 143(a) (annual fees not paid) or expired